The development of not one but several Covid-19 vaccines in a mere matter of months has captured the imagination of investors. With the biotechnology sector firmly in the spotlight, investors are wondering how to access the lifesaving innovation on display.
However, biotech is a deep and complex sector, which requires extensive expertise to navigate. Scientific discoveries occur in all corners of the globe, but to gain exposure to the drugs providing solutions to the world's most complex conditions, investors should look to US companies listed on the NASDAQ Biotechnology Index. In order to understand why the US has become such a biotech behemoth, investors must follow the journey from brains to business. Going for the golden mean: Now is an exciting time to have a diverse biotech portfolio All roads lead to America Innovation often ...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
